|
Obinutuzumab 25 MG/1 ML Intravenous Solution [GAZYVA] Clinical Trials
1 actively recruiting trial across 1 location
Also known as: GAZYVA
Scottsdale, Arizona1 trial
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
HonorHealth Research Institute
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.